CSO open letter to the Director General of the WTO on TRIPS Waiver

COVID-19

Download

Photograph by Sophia Apostolia

MSF joined this open letter with civil society organizations (CSOs) to the Director General of the World Trade Organization (WTO), Dr. Ngozi Okonjo-Iweala, calling for prioritised engagement on the TRIPS Waiver proposal to remove intellectual-property barriers on and scale up production and supply of COVID-19 vaccines, therapeutics, diagnostics and other health tools.

Read, watch, share

Technical brief |

13 September 2022

Diagnostics

Africa-South Korea Roundtable: Working Together on Local Production of Diagnostics

Statement |

23 August 2022

Diagnostics

Principles for Access to Multi-disease Molecular Diagnostics

CSO open letter to the Director General of the WTO on TRIPS Waiver

Read, watch, share

Africa-South Korea Roundtable: Working Together on Local Production of Diagnostics

Principles for Access to Multi-disease Molecular Diagnostics

WTO adopts inadequate text, not a real Waiver on COVID monopolies

MSF responds to BioNTech announcement that it will set up first “BioNTainers” by end of 2022

Inability to agree a real pandemic intellectual property Waiver at WTO is a devastating global failure for people the world over

Trade Ministers at WTO should not accept current draft of Ministerial Decision on TRIPS

MSF to governments negotiating at WTO: get it right and adopt the real TRIPS Waiver

German government must push BioNTech to urgently transfer mRNA vaccine technology